announcement

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update

June 19, 2025 01:00 ET  | Source: Addex Therapeutics Strong cash position of CHF2.8 million at end of Q1 2025GABAB…

4 months ago

Applied Intuition Closes Series F at $15 Billion Valuation, Accelerating Vehicle Intelligence Across All Moving Machines

Closed in just over a year since the Series E announcement, this transaction demonstrates the company's hypergrowth and cements its…

4 months ago

CGTN: Second China-Central Asia Summit eyes a closer China-Central Asia community with a shared future

BEIJING, June 14, 2025 /PRNewswire/ -- Following the announcement by China's Foreign Ministry that President Xi Jinping will attend the second…

4 months ago

From LINE to Global: Slime Miner Hits $2M Monthly and Leads Kaia Growth

Singapore , June 14, 2025 (GLOBE NEWSWIRE) -- The Web3 hit game leads Kaia’s growth and sets a new benchmark…

4 months ago

cBrain appoints new CFO

Company Announcement no. 07/2025 cBrain appoints new CFO Copenhagen, June 11, 2025 cBrain (NASDAQ: CBRAIN) is happy to announce that…

4 months ago

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

June 06, 2025 16:00 ET  | Source: Zealand Pharma Company announcement – No. 14 / 2025 Zealand Pharma increases its…

4 months ago

Quantum Metal Recovery Inc. Responds to Besra Gold’s ASX Announcement, Initiates Legal Proceedings in Ontario

PENANG, Malaysia, June 6, 2025 /PRNewswire/ -- Quantum Metal Recovery Inc. (QMRI), the largest shareholder of Besra Gold Inc. (Besra),…

4 months ago

Olympism365 Summit day one: first concrete commitments made for a sustainable future through sport

04 June 2025 - The Olympism365 Summit: Sport for a Better World, hosted by the International Olympic Committee (IOC) in Lausanne, wrapped…

4 months ago

Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them

Company announcement no. 7/2025 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to…

4 months ago

Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant…

5 months ago